Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

36 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Reprogramming dysfunctional CD8+ T cells to promote properties associated with natural HIV control.
Perdomo-Celis F, Passaes C, Monceaux V, Volant S, Boufassa F, de Truchis P, Marcou M, Bourdic K, Weiss L, Jung C, Bourgeois C, Goujard C, Meyer L, Müller-Trutwin M, Lambotte O, Sáez-Cirión A. Perdomo-Celis F, et al. J Clin Invest. 2023 Jan 17;133(2):e167843. doi: 10.1172/JCI167843. J Clin Invest. 2023. PMID: 36647831 Free PMC article. No abstract available.
Primary role of type I interferons for the induction of functionally optimal antigen-specific CD8+ T cells in HIV infection.
Cabral-Piccin MP, Papagno L, Lahaye X, Perdomo-Celis F, Volant S, White E, Monceaux V, Llewellyn-Lacey S, Fromentin R, Price DA, Chomont N, Manel N, Saez-Cirion A, Appay V. Cabral-Piccin MP, et al. Among authors: perdomo celis f. EBioMedicine. 2023 May;91:104557. doi: 10.1016/j.ebiom.2023.104557. Epub 2023 Apr 12. EBioMedicine. 2023. PMID: 37058769 Free PMC article.
CD8 + T-cell priming is quantitatively but not qualitatively impaired in people with HIV-1 on antiretroviral therapy.
Cabral-Piccin MP, Briceño O, Papagno L, Liouville B, White E, Perdomo-Celis F, Autaa G, Volant S, Llewellyn-Lacey S, Fromentin R, Chomont N, Price DA, Sáez-Cirión A, Lambotte O, Katlama C, Appay V. Cabral-Piccin MP, et al. Among authors: perdomo celis f. AIDS. 2024 Feb 1;38(2):161-166. doi: 10.1097/QAD.0000000000003746. Epub 2023 Oct 5. AIDS. 2024. PMID: 37800637
In-depth virological and immunological characterization of HIV-1 cure after CCR5Δ32/Δ32 allogeneic hematopoietic stem cell transplantation.
Jensen BO, Knops E, Cords L, Lübke N, Salgado M, Busman-Sahay K, Estes JD, Huyveneers LEP, Perdomo-Celis F, Wittner M, Gálvez C, Mummert C, Passaes C, Eberhard JM, Münk C, Hauber I, Hauber J, Heger E, De Clercq J, Vandekerckhove L, Bergmann S, Dunay GA, Klein F, Häussinger D, Fischer JC, Nachtkamp K, Timm J, Kaiser R, Harrer T, Luedde T, Nijhuis M, Sáez-Cirión A, Schulze Zur Wiesch J, Wensing AMJ, Martinez-Picado J, Kobbe G. Jensen BO, et al. Nat Med. 2023 Mar;29(3):583-587. doi: 10.1038/s41591-023-02213-x. Epub 2023 Feb 20. Nat Med. 2023. PMID: 36807684 Free PMC article.
Early antiretroviral therapy favors post-treatment SIV control associated with the expansion of enhanced memory CD8+ T-cells.
Passaes C, Desjardins D, Chapel A, Monceaux V, Lemaitre J, Mélard A, Perdomo-Celis F, Planchais C, Gourvès M, Dimant N, David A, Dereuddre-Bosquet N, Barrail-Tran A, Gouget H, Guillaume C, Relouzat F, Lambotte O, Guedj J, Müller-Trutwin M, Mouquet H, Rouzioux C, Avettand-Fenoël V, Le Grand R, Sáez-Cirión A. Passaes C, et al. Among authors: perdomo celis f. Nat Commun. 2024 Jan 11;15(1):178. doi: 10.1038/s41467-023-44389-3. Nat Commun. 2024. PMID: 38212337 Free PMC article.
Frequency, Markers and Costs of Secondary Bacterial Infection in Pediatric Dengue.
Salgado D, Silva JM, Salcedo A, Losada PX, Niño AP, Molano M, Bermeo JM, Restrepo R, Perdomo-Celis F, Narváez CF, Toro JF. Salgado D, et al. Among authors: perdomo celis f. Pediatr Infect Dis J. 2024 Feb 1;43(2):123-129. doi: 10.1097/INF.0000000000004156. Epub 2023 Nov 6. Pediatr Infect Dis J. 2024. PMID: 37930223
Corrigendum: Cross-reactive humoral and CD4+ T cell responses to Mu and Gamma SARS-CoV-2 variants in a Colombian population.
Martel F, Cuervo-Rojas J, Ángel J, Ariza B, González JM, Ramírez-Santana C, Acosta-Ampudia Y, Murcia-Soriano L, Montoya N, Cardozo-Romero CC, Valderrama-Beltrán SL, Cepeda M, Castellanos JC, Gómez-Restrepo C, Perdomo-Celis F, Gazquez A, Dickson A, Brien JD, Mateus J, Grifoni A, Sette A, Weiskopf D, Franco MA. Martel F, et al. Among authors: perdomo celis f. Front Immunol. 2023 Aug 16;14:1274753. doi: 10.3389/fimmu.2023.1274753. eCollection 2023. Front Immunol. 2023. PMID: 37662943 Free PMC article.
Cross-reactive humoral and CD4+ T cell responses to Mu and Gamma SARS-CoV-2 variants in a Colombian population.
Martel F, Cuervo-Rojas J, Ángel J, Ariza B, González JM, Ramírez-Santana C, Acosta-Ampudia Y, Murcia-Soriano L, Montoya N, Cardozo-Romero CC, Valderrama-Beltrán SL, Cepeda M, Castellanos JC, Gómez-Restrepo C, Perdomo-Celis F, Gazquez A, Dickson A, Brien JD, Mateus J, Grifoni A, Sette A, Weiskopf D, Franco MA. Martel F, et al. Among authors: perdomo celis f. Front Immunol. 2023 Jul 27;14:1241038. doi: 10.3389/fimmu.2023.1241038. eCollection 2023. Front Immunol. 2023. PMID: 37575243 Free PMC article.
Unique Immune Blood Markers Between Severe Dengue and Sepsis in Children.
Salgado DM, Rivera GM, Pinto WA, Rodríguez J, Acosta G, Castañeda DM, Vega R, Perdomo-Celis F, Bosch I, Narváez CF. Salgado DM, et al. Among authors: perdomo celis f. Pediatr Infect Dis J. 2023 Sep 1;42(9):792-800. doi: 10.1097/INF.0000000000003990. Epub 2023 Jul 18. Pediatr Infect Dis J. 2023. PMID: 37463399
Recent advances in CD8+ T cell-based immune therapies for HIV cure.
Arenas VR, Rugeles MT, Perdomo-Celis F, Taborda N. Arenas VR, et al. Among authors: perdomo celis f. Heliyon. 2023 Jun 20;9(6):e17481. doi: 10.1016/j.heliyon.2023.e17481. eCollection 2023 Jun. Heliyon. 2023. PMID: 37441388 Free PMC article. Review.
36 results